Bachem Holding AG (FRA:BHM) Valuation Rank

View and export this data going back to 2023. Start your Free Trial

What is Bachem Holding AG Valuation Rank?

The Valuation Rank measures the current valuation of a business relative to other companies in the same industry and its own historical valuation. The companies are split in equal numbers and then ranked from 1 to 10, with 10 as the most undervalued and 1 as the most overvalued.

Three factors:
- Absolute valuation (medpsvalue) relative to current stock price, rank among all companies
- Historical valuation over the past 10 years. Rank pe, ps, pocf, ev2ebit over their own historical values
- Industry relative valuation
Companies without enough data is not ranked
Companies with negative earnings are ranked lower

These three factors are used to calculate the value score for every eligible company, with values from 1 to 10. The final ranked companies are split in equal numbers and ranked from 1 to 10, with 10 as the most undervalued, and 1 as the most overvalued. The numbers of companies in each rank are the same.

Bachem Holding AG Valuation Rank Related Terms

Thank you for viewing the detailed overview of Bachem Holding AG's Valuation Rank provided by GuruFocus.com. Please click on the following links to see related term pages.

Bachem Holding AG Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Basic Materials » Chemicals » Bachem Holding AG (FRA:BHM) » Definitions » Valuation Rank

Comparable Companies

Traded in Other Exchanges

BCHMY:USA BANBz:UK 0QND:UK BANB:Switzerland

Address

Hauptstrasse 144, Bubendorf, CHE, 4416

Website

https://www.bachem.com

Bachem Holding AG is a biochemical company that provides services to the pharmaceutical and biotechnology industry. It focuses on specializing in the development and manufacture of peptides and oligonucleotides. The group markets its products under the Bachem and Clinalfa brands. It has two geographic segments Europe/Asia and North America. Its products and services are CMC Development, Commercial API, Research and Specialities, and Services and Capabilities.